Articles tagged "Kidney transplantation"

2016 American Transplant Congress
A Visualization Software Platform for Managing a Kidney Paired-Donation Program.
M. Bray,¹ W. Wang,¹ M. Rees,² P. Song,¹ A. Leichtman,³ V. Ashby,¹ J. Kalbfleisch.¹
¹University of Michigan, Ann Arbor, MI; ²University of Toledo, Toledo, OH; ³Arbor Research, Ann Arbor, MI.
A kidney paired-donation (KPD) program's aim is typically to maximize the number of transplants achieved via cycles among incompatible donor-candidate pairs, as well as chains…
2016 American Transplant Congress
Factors Associated with Response to Plasmapheresis in Patients with Recurrent FSGS.
J. Shoji,¹ V. Tatapudi,² Z. Laszik,¹ A. Jones,³ J. Wolf,⁴ D. Adey,¹ F. Vincenti.¹
¹Department of Medicine, Division of Nephrology, University of California-San Francisco, California, CA; ²Department of Medicine, Division of Nephrology, New York University, New York, NY; ³Department of Sociology, George Washington University, Washington, DC; ⁴Transplant Surgery, Piedmont Transplant Institute, Atlanta, GA.
Background:Idiopathic focal segmental glomerulosclerosis (FSGS) is one of the primary glomerular diseases that commonly recurs in renal allograft and is known to be associated with…
2016 American Transplant Congress
Risk of Peritoneal Dialysis Catheter-Associated Peritonitis Following Kidney Transplant.
A. Rizzi,¹ S. Ruitta,¹ J. Peterson,¹ G. Gagin,¹ D. Fritze,¹ R. Sung,¹ Y. Lu,² K. Woodside.¹
¹Department of Surgery, University of Michigan, Ann Arbor, MI; ²Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
While peritoneal dialysis (PD) has become more common, PD catheter management at the time of kidney transplant varies widely by transplant center. We sought to…
2016 American Transplant Congress
Do Powerful Induction Antibodies Increase Post Renal Transplant Infections?
M. John, I. Dortonne, B. Kim, C. Li, M. Killackey, A. Paramesh, B. Lee, R. Zhang, G. Parker, J. Buell.
Transplant Institute, Tulane University School of Medicine, New Orleans, LA.
Purpose: Infection is one of the most common and costly complications of solid organ transplantation. Alemtuzemab (AL) is a powerful antibody that significantly reduced rejection…
2016 American Transplant Congress
Determinants of 1 Year Graft Loss After Pre Kidney Transplant Bariatric Surgery.
G. Mour, J. Zhang, Z. Su, D. Taber, P. Mauldin, T. Srinivas.
Medical Unversity of South Carolina, Charleston, SC.
Background: Bariatric surgery (BS) is increasingly used to manage weight pre-transplantation (Pre-Tx). However, grafts may be compromised by variable drug absorption, rejection and oxalate nephropathy.…
2016 American Transplant Congress
Implementation of Telehealth Is Associated with Improved Timeliness of Kidney Transplant Waitlist Evaluation at a VA Center.
R. Forbes,^1,2 K. Kummerow Broman,^1,2 T. Johnson,² D. Rybacki,² M. Hagemann,² A. Hannah-Gillis,² I. Feurer,¹ D. Hale.^1,2
¹TN Valley HS, Nashville, TN; ²Vanderbilt University Medical Center, Nashville, TN.
Background: The VA National Transplant Program is challenged to provide timely kidney transplant evaluation for Veterans nationwide. Efforts to improve access have included implementing a…
2016 American Transplant Congress
Does Post-Transplant Adherence Come at a Cost?
K. Yadav, T. Nevins, D. Vock, W. Thomas, W. Robiner, A. Matas.
University of Minnesota, Minneapolis, MN.
Background: It is well documented that organ transplant (tx)recipients have an increased incidence of cancer including virus associated cancers like lymphoma. Our objective was to…
2016 American Transplant Congress
Influence of Lipid Levels on Cardiovascular Events After Early Conversion from Calcineurin Inhibitor to Everolimus: 24 M Analysis of the ELEVATE Study.
M. van der Giet,¹ J. de Fijter,¹ F. Oppenheimer,¹ L. Toselli,¹ G. Russ,¹ P. Lopez,² J. Aguilar,² P. Bernhardt,² Z. Wang,³ J. Cruzado,¹ H. Holdaas.¹
¹ELEVATE study group, Berlin, Germany; ²Novartis pharma AG, Basel, Switzerland; ³Novartis Pharmaceutical Corporation, East Hanover, NJ.
Background: Immunosuppressive therapies are probably the most important cause of hyperlipidemia post-renal transplantation (RTx). Lipid abnormalities represent important biomarkers for cardiovascular (CV) risk. Here, we…
2016 American Transplant Congress
How Did the New Kidney and Pancreas Allocation Systems Effect Pancreas Utilization in the First Six-Months?
R. Carrico,¹ J. Fridell,² J. Odorico,³ Z. Stewart.⁴
¹UNOS, Richmond, VA; ²Indiana Univ School of Medicine, Indianapolis, IN; ³Univ of Wisconsin Hospital and Clinics, Madison, WI; ⁴Univ of Iowa Hospital and Clinics, Iowa City, IA.
Background: In 2010 a new pancreas allocation system (PAS) was approved by the OPTN and implemented in October 2014, shortly preceding the new kidney allocation…
2016 American Transplant Congress
Return on Investment for Financial Assistance for Living Kidney Donors in the United States.
A. Mathur,¹ J. Xing,² D. Dickinson,² P. Warren,³ K. Gifford,³ B. Hong,⁴ A. Ojo,⁵ R. Merion.^2,5
¹Mayo Clinic, Phoenix; ²Arbor Research Collaborative for Health, Ann Arbor; ³ASTS, Arlington; ⁴Washington University in St. Louis, St. Louis; ⁵University of Michigan, Ann Arbor.
Background: Federal financial support through the National Living Donor Assistance Center (NLDAC) assists potential living donors who have prohibitive out-of-pocket expenses. We calculated the return…